CASC3 and Hepatic fibrosis: Although the mechanisms of BTZ function in liver fibrosis remain incompletely understood, it exerts its antifibrotic action mainly by inhibiting the NF-κB pathway components associated with TGF-β1 during the inducing apoptotic process.